Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Peymani

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Medical Oncology (Northwood, London, England)|February 12, 2022
In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivityReza Hashemi, Maryam Peymani, Kamran Ghaedi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 5, 2024
Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS gene and efficacy of Oleuropein-conjugated iron oxide nanoparticlesSedigheh Mehdinejad, Maryam Peymani, Ali Salehzadeh, et al.
Molecular Biology Reports|August 10, 2021
LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effectNajmeh Riahi Zaniani, Andisheh Oroujalian, Ali Valipour, et al.
Human Immunology|June 18, 2022
Circulating long noncoding RNAs as novel bio-tools: Focus on autoimmune diseasesBahareh Karimi, Ali Dehghani Firoozabadi, Maryam Peymani, et al.
Nucleosides, Nucleotides & Nucleic Acids|January 18, 2022
<i>PSAT1</i> gene as a biomarker for targeting triple negative breast cancer in presence of RapamycinMehdi Roshanian Bakhsh, Maryam Peymani, Leila Rouhi, et al.
Biological Trace Element Research|October 4, 2023
Exploring the Therapeutic Potential of Fe<sub>3</sub>O<sub>4</sub>@Glu-Oleuropein Nanoparticles in Targeting KRAS Pathway-Regulating lncRNAs in Colorectal Cancer CellsZahra Mahdavi Niyaki, Ali Salehzadeh, Maryam Peymani, et al.
Molecular Genetics & Genomic Medicine|September 18, 2018
miR-34a/BCL-2 signaling axis contributes to apoptosis in MPPZahra Shanesazzade, Maryam Peymani, Kamran Ghaedi, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 9, 2019
Association study of rs10768683 and rs968857 polymorphisms with transfusion-dependent thalassemia (TDT) in a southern Iranian populationZahed Barati, Marziye Farsimadan, Alireza Sharafshah, et al.
Iranian Journal of Biotechnology|February 22, 2023
The PBX1/miR-141-miR-200a/EGR2/SOCS3 Axis; Integrative Analysis of Interaction Networks to Discover the Possible Mechanism of MiR-141 and MiR-200a-Mediated Th17 Cell DifferentiationLeila Bahmani, Masoud Baghi, Maryam Peymani, et al.
Tissue & Cell|November 2, 2023
Decellularized tracheal scaffold as a promising 3D scaffold for tissue engineering applicationsAida Nahumi, Maryam Peymani, Asadollah Asadi, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Medical Oncology (Northwood, London, England)|February 12, 2022
In silico identification of the specific pathways in each stage of colorectal cancer and the association of their top genes with drug resistance and sensitivityReza Hashemi, Maryam Peymani, Kamran Ghaedi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 5, 2024
Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS gene and efficacy of Oleuropein-conjugated iron oxide nanoparticlesSedigheh Mehdinejad, Maryam Peymani, Ali Salehzadeh, et al.
Molecular Biology Reports|August 10, 2021
LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effectNajmeh Riahi Zaniani, Andisheh Oroujalian, Ali Valipour, et al.
Human Immunology|June 18, 2022
Circulating long noncoding RNAs as novel bio-tools: Focus on autoimmune diseasesBahareh Karimi, Ali Dehghani Firoozabadi, Maryam Peymani, et al.
Nucleosides, Nucleotides & Nucleic Acids|January 18, 2022
<i>PSAT1</i> gene as a biomarker for targeting triple negative breast cancer in presence of RapamycinMehdi Roshanian Bakhsh, Maryam Peymani, Leila Rouhi, et al.
Biological Trace Element Research|October 4, 2023
Exploring the Therapeutic Potential of Fe<sub>3</sub>O<sub>4</sub>@Glu-Oleuropein Nanoparticles in Targeting KRAS Pathway-Regulating lncRNAs in Colorectal Cancer CellsZahra Mahdavi Niyaki, Ali Salehzadeh, Maryam Peymani, et al.
Molecular Genetics & Genomic Medicine|September 18, 2018
miR-34a/BCL-2 signaling axis contributes to apoptosis in MPPZahra Shanesazzade, Maryam Peymani, Kamran Ghaedi, et al.
Nucleosides, Nucleotides & Nucleic Acids|March 9, 2019
Association study of rs10768683 and rs968857 polymorphisms with transfusion-dependent thalassemia (TDT) in a southern Iranian populationZahed Barati, Marziye Farsimadan, Alireza Sharafshah, et al.
Iranian Journal of Biotechnology|February 22, 2023
The PBX1/miR-141-miR-200a/EGR2/SOCS3 Axis; Integrative Analysis of Interaction Networks to Discover the Possible Mechanism of MiR-141 and MiR-200a-Mediated Th17 Cell DifferentiationLeila Bahmani, Masoud Baghi, Maryam Peymani, et al.
Tissue & Cell|November 2, 2023
Decellularized tracheal scaffold as a promising 3D scaffold for tissue engineering applicationsAida Nahumi, Maryam Peymani, Asadollah Asadi, et al.
Pageof 9